News Industry Incentives May Drive Pricier Anti-VEGF Drug Use by Medscape • 2016/06/23 • 0 Comments Ophthalmologists with the most and largest payments had highest rates of injection with aflibercept and ranibizumab. Medscape Medical News Full Story →